Brief: Silo Pharma announces Formation Of Joint Venture With Hoth Therapeutics
25/06/2025 13:32
June 25 (Reuters) - Hoth Therapeutics Inc HOTH.O: SILO PHARMA: FORMATION OF STRATEGIC JOINT VENTURE WITH HOTH THERAPEUTICS SILO PHARMA: JOINT VENTURE TO DEVELOP FIRST-IN-CLASS GDNF-BASED THERAPY LICENSED FROM U.S. DEPARTMENT OF VETERANS AFFAIRS Source text: ID:nPn4b6dFMa Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology